Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Pfizer Inc
Relationship:   10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   139,025,200    

Indirect Shares

   102,923,921      
Direct Value   $1,166,693,014    

Indirect Value

   $123,922,254      
Total Shares   241,949,121      
Total Value   $1,290,615,268      


EyePoint Pharmaceuticals Inc $32,959,058 Icagen Inc $0 Celladon Corp $0 Flexion Therapeutics Inc $15,387,720 Neurogene $3,589,483 Synlogic Inc $694,533 Allogene Therapeutics, Inc. $0 Cerevel Therapeutics Holdings, Inc. $1,099,835,815 Oric Pharmaceuticals, Inc. $0 Zura Bio Ltd $14,226,405 EyePoint Pharmaceuticals Inc $32,959,058 Icagen Inc $0 Celladon Corp $0 Flexion Therapeutics Inc $15,387,720 Neurogene $3,589,483 Synlogic Inc $694,533 Allogene Therapeutics, Inc. $0 Cerevel Therapeutics Holdings, Inc. $1,099,835,815 Oric Pharmaceuticals, Inc. $0 Zura Bio Ltd $14,226,405
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   111.8%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Arqule Inc ARQL 10% Owner 2003-12-17 0 2003-12-17 3,273,679    Premium*  
            EyePoint Pharmaceuticals Inc EYPT 10% Owner 2007-08-27 74,483,748 0    Premium*  
            Coley Pharmaceutical Group, Inc. COLY 10% Owner 0 2007-12-28 24,423,732    Premium*  
            Icagen Inc ICGN 10% Owner 2011-09-02 1,067,015 2011-09-02 4,611,921    Premium*  
            Encysive Pharmaceuticals Inc ENCY 10% Owner 2008-04-01 0 2008-04-14 69,076,466    Premium*  
            Zoetis Inc. ZTS 10% Owner 2013-06-24 0 0    Premium*  
            Five Prime Therapeutics Inc FPRX 10% Owner 0 2013-09-17 1,538,123    Premium*  
            Celladon Corp CLDN 10% Owner 2014-02-04 1,794,803 2014-02-04 0    Premium*  
            Flexion Therapeutics Inc FLXN 10% Owner 2014-02-18 1,687,250 2014-02-18 0    Premium*  
            Neurogene NGNE 10% Owner 2015-08-10 975,403 2014-03-12 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-06 2,489,364 2015-10-05 0    Premium*  
            Allogene Therapeutics, Inc. ALLO 10% Owner 2018-10-15 22,032,040 2018-10-15 0    Premium*  
            Upjohn Inc VTRS 10% Owner 2020-11-16 0 0    Premium*  
            Cerevel Therapeutics Holdings, I... CERE 10% Owner 2020-10-27 26,149,211 2020-10-27 0    Premium*  
            Oric Pharmaceuticals, Inc. ORIC 10% Owner 2022-12-23 5,376,344 0    Premium*  
            Zura Bio Ltd ZURA 10% Owner 2023-03-20 2,970,022 0    Premium*  
* Premium Members only  

Records found :    44         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALLO Allogene Therapeutics, In... 10% Owner   –       –       •   2018-10-15 4 A $0.00 $0 D/D 21,976,484 21,976,484 0 -
ALLO Allogene Therapeutics, In... 10% Owner   –       –       •   2018-10-15 4 B $18.00 $1,000,008 D/D 55,556 22,032,040 2.45 -
ARQL Arqule Inc 10% Owner   –       –       •   2003-12-17 4 A $2.67 $1,722,583 I/I 645,162 3,273,679 -
CLDN Celladon Corp 10% Owner   –       –       •   2014-02-04 4 B $8.00 $1,818,088 D/D 227,261 1,794,803 2.45 -
CLDN Celladon Corp 10% Owner   –       –       •   2014-02-04 4 A $0.00 $185,160 D/D 1,567,542 1,567,542 0 -
CERE Cerevel Therapeutics Hold... 10% Owner   –       –       •   2020-10-27 3 IO $0.00 $0 D/D 0 26,149,211 %
CERE Cerevel Therapeutics Hold... 10% Owner   –       –       •   2020-10-27 4 B $10.00 $12,000,000 D/D 1,200,000 27,349,211 2.45 %
COLY Coley Pharmaceutical Grou... 10% Owner   –       –       •   2007-12-28 3 IO $0.00 $0 I/I 0 24,423,732 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-01 4/A B $2.35 $391,665 I/I 166,666 61,931,961 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-01 3/A IO $0.00 $0 I/I 0 61,765,295 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-01 3 IO $0.00 $0 I/I 0 70,238,869 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-01 4 B $2.35 $413,381 I/I 175,907 70,414,776 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-02 4/A B $2.35 $2,149,103 I/I 914,512 62,846,473 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-02 4 B $2.35 $14,105 I/I 6,002 70,420,778 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-03 4 B $2.35 $4,252,708 I/I 1,809,663 64,656,136 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-04 4 B $2.35 $1,354,000 I/I 576,170 65,232,306 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-07 4 B $2.35 $5,178,037 I/I 2,203,420 67,435,726 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-08 4 B $2.35 $69,106 I/I 29,407 67,465,133 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-09 4 B $2.35 $29,676 I/I 12,628 67,477,761 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-10 4 B $2.35 $495,366 I/I 210,794 67,688,555 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-11 4 B $2.35 $365,423 I/I 155,499 67,844,054 1.5 -
ENCY Encysive Pharmaceuticals ... 10% Owner   –       –       •   2008-04-14 4 B $2.35 $2,896,168 I/I 1,232,412 69,076,466 1.5 -
EYPT EyePoint Pharmaceuticals ... 10% Owner   –       –       •   2007-08-27 3 IO $0.00 $0 D/D 0 74,483,748 -
FPRX Five Prime Therapeutics I... 10% Owner   –       –       •   2013-09-17 3 IO $0.00 $0 I/I 0 1,538,123 -
FLXN Flexion Therapeutics Inc 10% Owner   –       –       •   2014-02-18 4 A $0.00 $0 D/D 1,687,250 1,687,250 0 -
  44  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us